Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,972 | -26,478 | -20,794 | -15,402 | -5,063 |
| Accounts payable and accrued liabilities | 211 | 109 | 65 | 428 | 467 |
| Other Working Capital | 3,395 | -1,803 | -1,475 | -337 | -1,107 |
| Other Operating Activity | 33 | 5,530 | 5,340 | 4,367 | -285 |
| Operating Cash Flow | $-7,333 | $-22,642 | $-16,864 | $-10,944 | $-5,988 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 59,347 | 59,327 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | -681 | 0 |
| Financing Cash Flow | $N/A | $59,347 | $59,327 | $-681 | $N/A |
| Beginning Cash Position | 58,539 | 21,834 | 21,834 | 21,834 | 21,834 |
| End Cash Position | 51,206 | 58,539 | 64,297 | 10,209 | 15,846 |
| Net Cash Flow | $-7,333 | $36,705 | $42,463 | $-11,625 | $-5,988 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,333 | -22,642 | -16,864 | -10,944 | -5,988 |
| Free Cash Flow | -7,333 | -22,642 | -16,864 | -10,944 | -5,988 |